Home > Insider Trading > Tesaro Inc.

Tesaro Inc. (TSRO)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Here is What Hedge Funds Think About Tesaro Inc (TSRO)

Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that big brokerage houses don...

Keep Reading →

December 16th, 2018 - Hedge Funds News

Hedge Fund and Insider Trading News: Philip Falcone, Ray Dalio, Continental Resources, Inc. (CLR), Sandy Spring Bancorp Inc. (SASR), Independent Bank Group Inc (IBTX), and More

Philip Falcone is ready for a bigger house.

Keep Reading →

March 9th, 2018 - Hedge Funds Insider Trading

Hedge Fund and Insider Trading News: Kyle Bass, Corvex Management, Citadel Investment Group, WisdomTree Investments, Inc. (WETF), Zoe's Kitchen Inc (ZOES), TESARO Inc (TSRO), and More

Hedge fund manager Kyle Bass said possible U.S.

Keep Reading →

March 7th, 2018 - Hedge Funds Insider Trading

Here's Why TESARO Inc (TSRO) Fell Sharply

Shares of TESARO Inc (NASDAQ:TSRO) are off almost 10% in afternoon trading on Thursday after the company announced the wholesale cost of 30 pills of ZEJULA 200mg at around $9833 per month.

Keep Reading →

April 20th, 2017 - Market Movers News

Financial Markets Snapshot: 20+ Stories That You Should Read Today

"U.S. stocks were higher in on Thursday, with the S&P 500 index on track for its best day in about seven weeks, as American Express set the tone for the latest batch of earnings.

Keep Reading →

April 20th, 2017 - Commodities Gold Market Movers News Tech

AstraZeneca PLC (ADR) (AZN)'s Lynparza Trial Results Positive In Competitive Threat To Clovis Oncology Inc (CLVS) And TESARO Inc (TSRO)

Lynparza, an ovarian cancer treatment developed by AstraZeneca PLC (ADR) (NYSE:AZN) has demonstrated its ability to slow down disease progression.

Keep Reading →

March 16th, 2017 - News Stock Analysis

Here's What Just Happened With AstraZeneca PLC (ADR) (AZN), TESARO Inc (TSRO) And Clovis Oncology Inc (CLVS)

It’s been a big week for PARP inhibitors. AstraZeneca PLC (ADR) (NYSE:AZN) just put out data from a phase 3 investigation of its lead PARP asset Lynparza, and the data came out as impressive.

Keep Reading →

March 15th, 2017 - News Stock Analysis

Clovis Oncology Inc (CLVS)'s Ovarian Cancer Drug Faces Stiff Competition From AstraZeneca PLC (ADR) (AZN), TESARO Inc (TSRO)

According to Debjit Chattopadhyay, a Janney analyst, trials from AstraZeneca and Tesaro are likely to change the role of PARP inhibitors from being second to front-line treatments.

Keep Reading →

January 31st, 2017 - News Stock Analysis

The Three Most Important Questions For TESARO Inc (TSRO) Shareholders Right Now

TESARO Inc (NASDAQ:TSRO) took a bit of a hit early Thursday morning, as the FDA announced it had issued a complete response letter (CRL) to the company relating to its latest new drug application (NDA...

Keep Reading →

January 13th, 2017 - News Stock Analysis